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A 67-year-old woman was referred to our department for further evaluation of her abnormal,
chest radiogram. Thorax computed tomography revealed a well-circumscribed, round mass in
the middle lobe of the right lung. A thoracotomy was performed and pulmonary sclerosing
hemangioma was diagnosed. We herein present a rare tumor of the lung.
ª 2012 Elsevier Ltd. All rights reserved.Introduction
Sclerosing hemangioma (pneumocytoma) is a rare benign
tumor of the lung with uncertain histogenesis that is
composed of two major cell types: surface and round cells.
Despite the implication by its name of a vascular neoplasm,
sclerosing hemangioma is considered by most authorities to
be an epithelial tumor, possibly related to the pulmonary
epithelium (type II pneumocyte). Because of this, some
investigators call this tumor “pneumocytoma”.gmai l.com (A. Baysak),
A.T. Oz), kcanceylan@gmail.
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12.12.005It is a well-circumscribed lung parenchymal lesion. This
tumor is usually seen in the fifth decaded females. Most of
the patients are asymptomatic. They have usually an inci-
dental lung mass on chest radiograms. Computerized
tomography is characterized with well defined juxtapleural
mass. Calcification may be seen often (41% of the tumor
have calcification on microscopic examination). We herein
report a case of a rare lung tumor called sclerosing
hemangioma or “pneumocytoma”.
Case
A 67-year-old woman who presented with a one-month
history of non productive cough and upper back pain was
referred to local the Department of Chest Diseases of State
Hospital. The chest X-ray on admission showed a round.
Figure 1 A, B: The mass lesion localized infrahilar and paracardiac area and eventration of the right diaphragma in the chest X-
ray. C, D: A round lesion located in the middle lobe of the right lung in thorax CT.
Sclerosing hemangioma, pneumocytoma, lung tumor 449mass lesion on the right paracardiac area. For further
investigation, she was referred to Ege University Medical
School, Chest Diseases Department. She had a history of 20
pack/years and worked as afarmer for many years. She has
been taking antihypertensive drugs for 10 years. Physical
examination was normal on admission. LaboratoryFigure 2 A, B: Strands of sclerotic stroma separating blood-filled
cells. C, D: Both the lining and the polygonal cells were positive foexaminations including total blood count, bleeding time,
prothrombin time (PT), and activated partial thrombo-
plastin time (APTT), urine analysis, arterial blood gas
analysis were within normal ranges except the erthrocyte
sedimentation rate (60 mm/h). In biochemical analysis, the
blood urea and creatinin were moderately high. The chestspaces lined by flattened cells; pathcy sheets of small polygonal
r TTF-1 and EMA, weakly positive for AE1/AE3.
450 A. Baysak et al.X-ray on admission showed a round, well circumscribed
mass lesion localized infrahilar and paracardiac area and
eventration of the right diaphragma (Fig. 1A, B). A thorax
computed tomography (CT) revealed a round lesion located
in the middle lobe of the right lung. The tumor was 3.5 cm
in diameter (Fig. 1C, D).
Abdominal ultrasonography was normal. The fiberoptic
bronchoscopic examination was normal with no malignant
cell histology. She underwent a right posterolateral thora-
cotomy and enucleation of the tumor was performed. She
was discharged without any complications on the seventh
postoperative day. The pathological examination of the
specimen revealed a lung architecture which was replaced
by strands of sclerotic stroma separating blood-filled spaces
lined by flattened cells. There were pathcy sheets of small
polygonal cells (Fig. 2A, B). Both the lining and the polyg-
onal cells were positive for TTF-1 and EMA, weakly positive
for AE1/AE3 (Fig. 2C, D). In the immunohistochemical
examination, CD1a and S-100 staining were negative and
there was no hemosiderin deposition. A Congo Red stain for
amyloid was negative. The pathologic appearances were
consisted with sclerosing hemangioma.
Discussion
Sclerosing hemangioma is a relatively rare benign tumor of
the lung. It is first described by Liebow and Hubell1 and
termed sclerosing hemangioma of the lung owing to prom-
inent sclerotization and vascularization of the tissue.
Pathologically, SH is typically composed of solid, papillary,
sclerotic or hemangiomatous components.2,4 The propor-
tions of these four components in the tumor typically vary,
although one of them tends to predominate.4,7 Ultrastruc-
tural and immunohistochemical studies have shown that
pulmonary sclerosing hemangioma is likely to be the
manifestation of the primary proliferation of epithelial
cells, probably type II pneumocytes, which may show
a neuroendocrine differentiation.4 The epithelial origin of
the tumor was also supported by TTF-1 and EMA positivity in
both the surface cells and round cells in the majority of the
cases.8 Pancytokeratin (AE1/3) usually reacts with surface
cells, and not with round cells.8 Tumor is well circum-
scribed but has not a definite capsule. It grows expansively
and compresses the neighboring parenchyma. The tumor is
clinically asymptomatic and occurs in young as well as in old
people. The peak age incidence is the 5th decade. Women
are affected by this tumor more frequently (F:M Z 5:1).
Based on the findings of higher incidence in females, both
estrogen receptors (ER) and progesterone receptors (PR)
were studied immunohistochemically. Most patients were
positive for both ER and PR, suggesting a relationship
between this tumor and female sex hormones.8 SH is often
detected incidentally as a round, well-defined homogenous
mass on routine chest radiograph.9 The greatest diameter
of the tumor on chest radiograph has ranged from 13 to
82 mm. Sometimes, in thorax computerized tomography,
air-trapping zone surrounding SH or air meniscus sign,
which is most commonly seen in aspergilloma, is observed.6
The tumor is rarely bilateral. Calcification has been re-
ported in 41% of sclerosing hemangiomas.4 Lymph nodemetastasis is extremely rare.5 Tanaka and colleagues in
1986 reported the first case of SH with lymph node
metastasis.8 Contralateral lung metastasis is also rarely
seen.7 Thorax CT and bronchoscopic examinations could not
make accurate diagnosis preoperatively. A thoracotomy is
usually indicated for definite diagnosis and treatment.10
The diagnosis is based on histo-pathohistologic examina-
tion of the biopsy material. Intraoperative frozen section
histology may prevent unnecessary resection of lung tissue.
Extracapsular enucleation is the treatment of choice for
SH.11 After surgery, the prognosis of patients is excellent.3
Lymph node dissection may be necessary to detect lymph
node metastasis in cases with a large SH or with enlarged
lymph nodes that may be due to metastasis.7
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